FR2215203B1 - - Google Patents

Info

Publication number
FR2215203B1
FR2215203B1 FR7402808A FR7402808A FR2215203B1 FR 2215203 B1 FR2215203 B1 FR 2215203B1 FR 7402808 A FR7402808 A FR 7402808A FR 7402808 A FR7402808 A FR 7402808A FR 2215203 B1 FR2215203 B1 FR 2215203B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7402808A
Other versions
FR2215203A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of FR2215203A1 publication Critical patent/FR2215203A1/fr
Application granted granted Critical
Publication of FR2215203B1 publication Critical patent/FR2215203B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR7402808A 1973-01-30 1974-01-29 Expired FR2215203B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US327894A US3880989A (en) 1973-01-30 1973-01-30 Production of antisera comprising fractionating plasma or serum with an ethylene oxide-polyoxypropylene block copolymer

Publications (2)

Publication Number Publication Date
FR2215203A1 FR2215203A1 (fr) 1974-08-23
FR2215203B1 true FR2215203B1 (fr) 1976-09-03

Family

ID=23278541

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7402808A Expired FR2215203B1 (fr) 1973-01-30 1974-01-29

Country Status (11)

Country Link
US (1) US3880989A (fr)
JP (1) JPS49109523A (fr)
AU (1) AU6495374A (fr)
BE (1) BE810218A (fr)
DE (1) DE2403994A1 (fr)
ES (1) ES422768A1 (fr)
FR (1) FR2215203B1 (fr)
GB (1) GB1418849A (fr)
IL (3) IL44008A (fr)
IT (1) IT1053753B (fr)
ZA (1) ZA74353B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148869A (en) * 1975-03-06 1979-04-10 Baxter Travenol Laboratories, Inc. Immunological reagent and method of using same
CA1064396A (fr) * 1975-02-18 1979-10-16 Myer L. Coval Precipitation fractionnee de la gamma globuline a l'aide de polyethylene glycol
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
DK139056B (da) * 1976-04-06 1978-12-11 Nordisk Insulinlab Fremgangsmåde til udvinding af immunoglobulin, der er egnet til intravenøs indgivelse.
US4057628A (en) * 1976-04-19 1977-11-08 William L. Wilson Removal of hepatitis associated antigen from plasma
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4357272A (en) * 1978-03-22 1982-11-02 The South African Inventions Development Corporation Recovering purified antibodies from egg yolk
DE2814981C3 (de) * 1978-04-07 1981-08-06 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Faktor zur Stimulation der Proliferationsrate von Leberzellen
JPS6029687B2 (ja) * 1978-11-07 1985-07-12 株式会社ミドリ十字 ヒト胎盤由来血液凝固第１０３因子の濃縮液の製造方法
DE2914903C2 (de) * 1979-04-12 1981-08-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Leberzellwachstumfaktor
US4919811A (en) * 1988-01-14 1990-04-24 The Standard Oil Company Affinity membranes having pendant hydroxy groups and processes for the preparation and use thereof
US5006287A (en) * 1988-01-14 1991-04-09 The Standard Oil Company Affinity membranes having pendant hydroxy groups and processes for the preparation and use thereof
JP2684069B2 (ja) * 1988-10-13 1997-12-03 昇一 首藤 免疫学的活性物質の測定方法及びそのための試薬

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
NL286954A (fr) * 1962-01-03
US3450502A (en) * 1967-09-25 1969-06-17 Wyandotte Chemicals Corp Method of operating heart-lung apparatus
US3770631A (en) * 1971-06-29 1973-11-06 Baxter Laboratories Inc Clarification of blood serum and plasma

Also Published As

Publication number Publication date
IL50191A (en) 1977-08-31
DE2403994A1 (de) 1974-08-08
ES422768A1 (es) 1976-08-01
BE810218A (fr) 1974-05-16
IL44008A0 (en) 1974-05-16
IL44008A (en) 1977-08-31
IL50191A0 (en) 1976-10-31
IT1053753B (it) 1981-10-10
FR2215203A1 (fr) 1974-08-23
JPS49109523A (fr) 1974-10-18
AU6495374A (en) 1975-07-31
US3880989A (en) 1975-04-29
GB1418849A (en) 1975-12-24
ZA74353B (en) 1974-11-27

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU471343B2 (fr)
AU465434B2 (fr)
FR2215203A1 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU466283B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AU477824B2 (fr)
AR193950A1 (fr)
AU471461B2 (fr)
AU461342B2 (fr)
AR200885A1 (fr)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse